San Raffaele Hospital-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:San Raffaele Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013406
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
San Raffaele hospital (San Raffaele), a subsidiary of Vita-Salute San Raffaele University is a clinical scientific university institution that offers education and healthcare services. The institute provides services through the segments clinic, scientific research, patient services, and hospital services. Its offers clinical and diagnostic medical services, medical services and public services charter. San Raffaele’s inpatient services include cardiac surgery, vascular surgery, general reconstructive surgery, nuclear medicine, neuroradiology, and others. The institute’s clinical services include inpatient services, specialty clinics, blood and marrow donation, emergency room, rare diseases, laboratory medicine, nuclear medicine and PET, radiology, radiotherapy, call center breast and lung cancers, health in the mirror, and charter services birth path. It also offers pre and post graduate education and research facilities. San Raffaele hospital is headquartered in Milan, Italy.

San Raffaele Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
San Raffaele Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Genenta Science and San Raffaele Hospital Enter into Agreement with Amgen 10
TxCell Enters into Research Agreement with Ospedale San Raffaele 11
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Enter into Agreement to Develop Gene Therapies for Hemophilia 12
Asset Transactions 13
MolMed Acquires CAR-CD44v6 Project from San Raffaele Hospital 13
San Raffaele Hospital – Key Competitors 14
San Raffaele Hospital – Key Employees 15
San Raffaele Hospital – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Sep 15, 2016: €12.6 Million Awarded to 3 Projects in Global Effort to End Progressive Multiple Sclerosis 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
San Raffaele Hospital, Pharmaceuticals & Healthcare, Key Facts 2
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
San Raffaele Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
San Raffaele Hospital, Deals By Therapy Area, 2011 to YTD 2017 8
San Raffaele Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genenta Science and San Raffaele Hospital Enter into Agreement with Amgen 10
TxCell Enters into Research Agreement with Ospedale San Raffaele 11
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Enter into Agreement to Develop Gene Therapies for Hemophilia 12
MolMed Acquires CAR-CD44v6 Project from San Raffaele Hospital 13
San Raffaele Hospital, Key Competitors 14
San Raffaele Hospital, Key Employees 15

★海外企業調査レポート[San Raffaele Hospital-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Churchill Downs Incorporated:企業の戦略・SWOT・財務情報
    Churchill Downs Incorporated - Strategy, SWOT and Corporate Finance Report Summary Churchill Downs Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Dome Investments Public Company Limited:企業の戦略・SWOT・財務情報
    Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • RTI Surgical Inc (RTIX)-医療機器分野:企業M&A・提携分析
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • Bata India Limited:企業の戦略・SWOT・財務情報
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WPG Resources Ltd (WPG):企業の財務・戦略的SWOT分析
    Summary WPG Resources Ltd (WPG) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, nickel, base metals, iron ore, and coal properties in South Australia. Its projects comprise Tunkillia gold project, Tarcoola gold …
  • Great Western Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Murphy USA Inc:企業の戦略・SWOT・財務分析
    Murphy USA Inc - Strategy, SWOT and Corporate Finance Report Summary Murphy USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nippon Soda Co., Ltd. (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co., Ltd. (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Bioneer Corp (064550):医療機器:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Intuit Inc (INTU):企業の財務・戦略的SWOT分析
    Intuit Inc (INTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • First Quantum Minerals Ltd:企業のM&A・事業提携・投資動向
    First Quantum Minerals Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Quantum Minerals Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Evofem Biosciences Inc (EVFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention …
  • Maroc Telecom SA (IAM):企業の財務・戦略的SWOT分析
    Maroc Telecom SA (IAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ePlus Inc (PLUS):企業の財務・戦略的SWOT分析
    ePlus Inc (PLUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • U-Shin Ltd.:企業の戦略的SWOT分析
    U-Shin Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mack-Cali Realty Corp (CLI):企業の財務・戦略的SWOT分析
    Mack-Cali Realty Corp (CLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • NeuroDerm Ltd (NDRM)-医療機器分野:企業M&A・提携分析
    Summary NeuroDerm Ltd (NeuroDerm) is a clinical stage pharmaceutical company that focuses on the development of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s levodopa/carbidopa (LD/CD) …
  • Zhejiang Yatai Pharmaceutical Co Ltd (002370):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Yatai Pharmaceutical Co Ltd (Yatai Pharmaceutical), formerly Asia-Pacific Pharmaceutical Factory, is a pharmaceutical company. The company develops, researches, and manufactures pharmaceuticals including penicillin, cephalosporins and hormones. It offers transdermal controlled-relea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆